Welltower Inc is a reit-healthcare facilities business based in the US. Welltower shares (WELL.US) are listed on the NYSE and all prices are listed in US Dollars. Welltower employs 443 staff and has a trailing 12-month revenue of around $4.7 billion.
|Latest market close||$N/A|
|52-week range||$23.3889 - $85.8659|
|50-day moving average||$63.5021|
|200-day moving average||$58.3905|
|Wall St. target price||$64.39|
|Dividend yield||$2.44 (3.87%)|
|Earnings per share (TTM)||$2.493|
All investing should be regarded as longer term. The value of your investments can go up and down, and you may get back less than you invest. Past performance is no guarantee of future results. If you’re not sure which investments are right for you, please seek out a financial adviser. Capital at risk.
The technical analysis gauge below displays real-time ratings for the timeframes you select. This is not a recommendation, however. It represents a technical analysis based on the most popular technical indicators: Moving Averages, Oscillators and Pivots. Finder might not concur and takes no responsibility.
Valuing Welltower stock is incredibly difficult, and any metric has to be viewed as part of a bigger picture of Welltower's overall performance. However, analysts commonly use some key metrics to help gauge the value of a stock.
Welltower's current share price divided by its per-share earnings (EPS) over a 12-month period gives a "trailing price/earnings ratio" of roughly 25x. In other words, Welltower shares trade at around 25x recent earnings.
That's relatively low compared to, say, the trailing 12-month P/E ratio for the NASDAQ 100 at the end of 2019 (27.29). The low P/E ratio could mean that investors are pessimistic about the outlook for the shares or simply that they're under-valued.
Welltower's "price/earnings-to-growth ratio" can be calculated by dividing its P/E ratio by its growth – to give 17.4271. A low ratio can be interpreted as meaning the shares offer better value, while a higher ratio can be interpreted as meaning the shares offer worse value.
The PEG ratio provides a broader view than just the P/E ratio, as it gives more insight into Welltower's future profitability. By accounting for growth, it could also help you if you're comparing the share prices of multiple high-growth companies.
Welltower's EBITDA (earnings before interest, taxes, depreciation and amortisation) is a whopping $2 billion.
The EBITDA is a measure of a Welltower's overall financial performance and is widely used to measure a its profitability.
|Revenue TTM||$4.7 billion|
|Operating margin TTM||20.62%|
|Gross profit TTM||$2.4 billion|
|Return on assets TTM||1.9%|
|Return on equity TTM||6.61%|
|Market capitalisation||$26.3 billion|
TTM: trailing 12 months
There are currently 9.2 million Welltower shares held short by investors – that's known as Welltower's "short interest". This figure is 7.2% up from 8.6 million last month.
There are a few different ways that this level of interest in shorting Welltower shares can be evaluated.
Welltower's "short interest ratio" (SIR) is the quantity of Welltower shares currently shorted divided by the average quantity of Welltower shares traded daily (recently around 2.7 million). Welltower's SIR currently stands at 3.42. In other words for every 100,000 Welltower shares traded daily on the market, roughly 3420 shares are currently held short.
However Welltower's short interest can also be evaluated against the total number of Welltower shares, or, against the total number of tradable Welltower shares (the shares that aren't held by "insiders" or major long-term shareholders – also known as the "float"). In this case Welltower's short interest could be expressed as 0.02% of the outstanding shares (for every 100,000 Welltower shares in existence, roughly 20 shares are currently held short) or 0.0288% of the tradable shares (for every 100,000 tradable Welltower shares, roughly 29 shares are currently held short).
Such a low SIR usually points to an optimistic outlook for the share price, with fewer people currently willing to bet against Welltower.
Find out more about how you can short Welltower stock.
Environmental, social and governance (known as ESG) criteria are a set of three factors used to measure the sustainability and social impact of companies like Welltower.
When it comes to ESG scores, lower is better, and lower scores are generally associated with lower risk for would-be investors.
Total ESG risk: 15.99
Socially conscious investors use ESG scores to screen how an investment aligns with their worldview, and Welltower's overall score of 15.99 (as at 01/01/2019) is excellent – landing it in it in the 9th percentile of companies rated in the same sector.
ESG scores are increasingly used to estimate the level of risk a company like Welltower is exposed to within the areas of "environmental" (carbon footprint, resource use etc.), "social" (health and safety, human rights etc.), and "governance" (anti-corruption, tax transparency etc.).
Environmental score: 12.01/100
Welltower's environmental score of 12.01 puts it squarely in the 9th percentile of companies rated in the same sector. This could suggest that Welltower is a leader in its sector terms of its environmental impact, and exposed to a lower level of risk.
Social score: 10.5/100
Welltower's social score of 10.5 puts it squarely in the 9th percentile of companies rated in the same sector. This could suggest that Welltower is a leader in its sector when it comes to taking good care of its workforce and the communities it impacts.
Governance score: 9.98/100
Welltower's governance score puts it squarely in the 9th percentile of companies rated in the same sector. That could suggest that Welltower is a leader in its sector when it comes to responsible management and strategy, and exposed to a lower level of risk.
|Total ESG score||15.99|
|Total ESG percentile||9.38|
|Environmental score percentile||9|
|Social score percentile||9|
|Governance score percentile||9|
Dividend payout ratio: 43.47% of net profits
Recently Welltower has paid out, on average, around 43.47% of net profits as dividends. That has enabled analysts to estimate a "forward annual dividend yield" of 3.87% of the current stock value. This means that over a year, based on recent payouts (which are sadly no guarantee of future payouts), Welltower shareholders could enjoy a 3.87% return on their shares, in the form of dividend payments. In Welltower's case, that would currently equate to about $2.44 per share.
While Welltower's payout ratio might seem fairly standard, it's worth remembering that Welltower may be investing much of the rest of its net profits in future growth.
Welltower's most recent dividend payout was on 19 November 2020. The latest dividend was paid out to all shareholders who bought their shares by 9 November 2020 (the "ex-dividend date").
Welltower's shares were split on a 3:2 basis on 4 September 1985. So if you had owned 2 shares the day before before the split, the next day you'd have owned 3 shares. This wouldn't directly have changed the overall worth of your Welltower shares – just the quantity. However, indirectly, the new 33.3% lower share price could have impacted the market appetite for Welltower shares which in turn could have impacted Welltower's share price.
Over the last 12 months, Welltower's shares have ranged in value from as little as $23.3889 up to $85.8659. A popular way to gauge a stock's volatility is its "beta".
Beta is a measure of a share's volatility in relation to the market. The market (NYSE average) beta is 1, while Welltower's is 1.0257. This would suggest that Welltower's shares are a little bit more volatile than the average for this exchange and represent, relatively-speaking, a slightly higher risk (but potentially also market-beating returns).
Welltower Inc. (NYSE:WELL), an S&P 500 company headquartered in Toledo, Ohio, is driving the transformation of health care infrastructure. The Company invests with leading seniors housing operators, post-acute providers and health systems to fund the real estate infrastructure needed to scale innovative care delivery models and improve people's wellness and overall health care experience. Welltower?, a real estate investment trust (REIT), owns interests in properties concentrated in major, high-growth markets in the United States, Canada and the United Kingdom, consisting of seniors housing and post-acute communities and outpatient medical properties.
Learn more about Transportation and Logistics Systems’ recent performance and where you can invest in Transportation and Logistics Systems shares. We also run through some helpful rules of thumb for any investor.
Learn more about Charlie’s Holdings’ recent performance and where you can invest in Charlie’s Holdings shares. We also run through some helpful rules of thumb for any investor.
Learn more about Lemonade’s recent performance and where you can invest in Lemonade shares. We also run through some helpful rules of thumb for any investor.
Learn more about Unity Software’s recent performance and where you can invest in Unity Software shares. We also run through some helpful rules of thumb for any investor
Learn more about FuelCell Energy’s recent performance and where you can invest in FuelCell Energy shares. We also run through some helpful rules of thumb for any investor.
Learn more about CloudCommerce’s recent performance and where you can invest in CloudCommerce shares. We also run through some helpful rules of thumb for any investor
Ever wondered how to buy shares in Zomedica Pharmaceuticals? We explain how and compare a range of providers that can give you access to many brands, including Zomedica Pharmaceuticals.
Ever wondered how to buy shares in YRC Worldwide? We explain how and compare a range of providers that can give you access to many brands, including YRC Worldwide.
Ever wondered how to buy shares in Xeros Technology Group? We explain how and compare a range of providers that can give you access to many brands, including Xeros Technology Group.
Ever wondered how to buy shares in Xpediator? We explain how and compare a range of providers that can give you access to many brands, including Xpediator.
finder.com is an independent comparison platform and information service that aims to provide you with the tools you need to make better decisions. While we are independent, the offers that appear on this site are from companies from which finder.com receives compensation. We may receive compensation from our partners for placement of their products or services. We may also receive compensation if you click on certain links posted on our site. While compensation arrangements may affect the order, position or placement of product information, it doesn't influence our assessment of those products. Please don't interpret the order in which products appear on our Site as any endorsement or recommendation from us. finder.com compares a wide range of products, providers and services but we don't provide information on all available products, providers or services. Please appreciate that there may be other options available to you than the products, providers or services covered by our service.